The Psychedelic Podcast
The Psychedelic Podcast connects you to the leaders and pioneers of the psychedelic renaissance. From deep healing to creativity, leadership to spirituality, business, health, human performance, relationships, sexuality, and even culture itself—every aspect of our world is being transformed by psychedelic medicines. Get an inspired, informed, balanced look into how these powerful medicines are already being safely and responsibly used to catalyze both personal and collective transformation. Whether you’re just curious or a seasoned psychonaut, or somewhere in between, you’ll get insightful, practical, cutting-edge conversations from the forefront of the psychedelic movement. Join us as we explore how psychedelics can be integrated into culture for the evolution of humanity.
info_outline
Why 5-MeO-DMT Doesn't Have to Be Explosive - Mira Funk, LCSW
10/05/2026
Why 5-MeO-DMT Doesn't Have to Be Explosive - Mira Funk, LCSW
In this episode of The Psychedelic Podcast, Paul F. Austin sits down with Mira Funk, LCSW, a Harvard-educated psychotherapist and the founder of , a private practice built around 5-MeO-DMT, N,N-DMT, and salvia divinorum. This episode is sponsored by Mira Funk. Mira traces her path from fourteen years of Zen meditation into psychedelic work, and explains how a severe reaction to a common nootropic supplement unexpectedly reoriented her entire practice toward presence rather than dramatic, otherworldly trips. She and Paul go deep on the extended-release routes she has pioneered, including subcutaneous, rectal, and vaginal 5-MeO-DMT, and the titrated e-mesh method she uses for salvia divinorum. Throughout the conversation, Mira is candid about the real risks of self-administration, the role of chronic illness in shaping her gentle approach, and why she believes structure matters most for those newest to this work. Mira Funk, LCSW (she/her), is a Harvard-educated queer, nonbinary psychotherapist and psychedelic guide specialized in 5-MeO-DMT, N,N-DMT (including analog ayahuasca), and salvia divinorum. Based in Oregon, she is the founder of Unjourneying, a private therapy practice blending somatic, nondual, and neuroscience-informed methods to optimize psychedelic healing and insight. Unjourneying draws its name from Neem Karoli Baba's reported non-response to LSD; observing this same effect in herself and long-term clients, Mira embraced the radically vivid here and now as her lodestar, rather than some mystical elsewhere. Having battled neurological Lyme disease for over three decades, Mira brings a gentle, trauma-informed approach to clients with physical and emotional challenges. She is the inventor of The Hourglass, a lung-friendly 5-MeO-DMT vaporization system with zero liquid carriers and two-stage cooling, and offers multiple extended-release routes of 5-MeO-DMT, including subcutaneous, rectal, and vaginal preparations for sexual trauma and pelvic floor dysfunction. She is currently the only psychedelic therapist in the field offering titrated dosing of pure salvinorin-A in an e-mesh format. Highlights: Fourteen years of Zen before mushrooms filled the gap Why structure helps most early in psychedelic work A supplement reaction that reshaped her entire practice 5-MeO-DMT as explosion versus something you can surf Building The Hourglass: her own zero-liquid vaporizer Subcutaneous, rectal & vaginal routes for 5-MeO-DMT A rectal 5-MeO-DMT session and healing pelvic trauma Real risks of DIY dosing and sourcing injectables safely Titrating salvia to a whisper with a custom e-mesh device Episode Links: Unjourneying (Mira's website): Mira on Instagram: YouTube: Patreon: This episode is also sponsored by: Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization.
/episode/index/show/psychedelia/id/43168608
info_outline
Why Medicalizing Psychedelics Is a Mistake - Dave Asprey
09/25/2026
Why Medicalizing Psychedelics Is a Mistake - Dave Asprey
Paul talks with biohacking pioneer Dave Asprey about medicalization, microdosing, consciousness, and Dave's new BEYOND Wonderland psychedelics conference in Austin. In this bonus episode, Paul welcomes back Dave Asprey, founder of Bulletproof Coffee and creator of the biohacking movement, to talk about BEYOND Wonderland, the psychedelics conference Dave has revamped for October 12-14 in Austin. They also get into medicalization, the CIA's documented role in psychedelic history, what responsible microdosing regulation could look like, and why Dave is as focused on unlocking latent human ability as he is on fixing what's broken. Want to attend BEYOND Wonderland? Get 10% off your ticket with code THIRDWAVE at (Code expires October 10). Episode links: BEYOND Wonderland – Use code THIRDWAVE for 10% off: Dave Asprey's website: Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can't and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn't responsible for the statements, conduct, services, or products of third parties. We receive a commission from sales arising from customers who use our coupon code. No one is required to use the coupon code. Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization.
/episode/index/show/psychedelia/id/43029328
info_outline
Psychedelics, AI, and the Right to Think - Ramez Naam
09/23/2026
Psychedelics, AI, and the Right to Think - Ramez Naam
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with computer scientist, climate investor, and Nexus author Ramez Naam about psychedelics, AI, neurotechnology, and cognitive liberty. Find full show notes and links here: Ramez shares how psychedelic experiences sparked his interest in neuroscience, inspired his books, and helped redirect his work toward climate and clean energy. He and Paul explore what brain-computer interfaces can do today, the future of psychedelic mental healthcare, and how to protect freedom of thought as AI becomes a more personal tool. Ramez Naam is a computer scientist, mission-focused investor, climate activist, and award-winning author of science fiction and nonfiction. His Nexus trilogy explores the possibilities of mind-to-mind communication technology, while his nonfiction examines human augmentation, neuroscience, climate, and clean energy. He serves as Co-Chair for Energy and Environment at Singularity University and invests through Planetary VC in companies working on clean energy, climate technology, and beneficial uses of AI. Highlights: How psychedelics inspired Ramez’s interest in neuroscience and his five books What today’s brain-computer interfaces can and cannot do Psilocybin, 5-MeO-DMT, and the future of mental healthcare Medicalization, decriminalization, and psychedelic access The LSD experience that helped shape Ramez’s climate work Clean energy progress and the challenges that remain AI privacy, cognitive liberty, and the freedom to think Episode Links: Ramez Naam’s website: Ramez Naam on X: Ramez Naam on Instagram: Episode Sponsors: Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization.
/episode/index/show/psychedelia/id/43003433
info_outline
Psychedelic Therapy Needs More Than Good Intentions - Kylea Taylor, M.S., LMFT
09/14/2026
Psychedelic Therapy Needs More Than Good Intentions - Kylea Taylor, M.S., LMFT
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with therapist and InnerEthics® founder Kylea Taylor about why responsible psychedelic therapy requires more than good intentions. Find full show notes and links here: Kylea explains why non-ordinary states can amplify intimacy, vulnerability, countertransference, and practitioner blind spots. She presents ethics as an ongoing practice of self-inquiry, restraint, and right relationship rather than a set of rules consulted only after something goes wrong. Paul and Kylea also examine personal experience as preparation for facilitation, the complexities of touch and consent, the meaning of inner healing intelligence, and why compassionate peer consultation is essential for anyone holding space in psychedelic work. Kylea Taylor, M.S., LMFT, is a California licensed therapist and the founder of InnerEthics®, a self-reflective approach to relational ethics taught in breathwork and psychedelic practitioner trainings. A certified Holotropic Breathwork® facilitator, she served as a senior trainer with Dr. Stanislav Grof throughout the 1990s. Kylea is the author of The Ethics of Caring and Peer Consultation Groups & Ethical Awareness Tools for Psychedelic Practitioners. She also co-founded SoulCollage®, helping train more than 6,000 facilitators across 63 countries. Highlights: Why non-ordinary states amplify ethical challenges Self-awareness and the practitioner’s blind spots Whether facilitators need personal experience with altered states Touch, consent, and client autonomy in psychedelic therapy Supporting inner healing intelligence without over-intervening Recognizing transference and countertransference Right relationship as a practical ethical compass Peer consultation and compassionate accountability Watch the full conversation on YouTube: Connect with Kylea: InnerEthics®: KyleaTaylor.com: Kylea Taylor’s books: InnerEthics® on Instagram: Kylea Taylor on LinkedIn: Episode Sponsors: Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone and do not reflect the views of any other person, company, or organization.
/episode/index/show/psychedelia/id/42894605
info_outline
Iboga Initiation and the Wisdom of Discomfort - Paije Alexandra West
09/07/2026
Iboga Initiation and the Wisdom of Discomfort - Paije Alexandra West
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Paije Alexandra West, founder of , about iboga, ibogaine, and Bwiti initiation. Drawing on Paul’s recent retreat experience at ETÉREO in Baja, they examine what can be lost when iboga is reduced to a clinical alkaloid and how traditional ceremony can coexist with rigorous medical screening. Paije explains the differences between iboga root bark and total alkaloid extract, the role of Bwiti music, and why discomfort, community, and long-term integration are central to working responsibly with this demanding medicine. Paije Alexandra West is the founder and lead iboga provider at ETÉREO | Center for Truth, an iboga retreat center outside Todos Santos, Baja California Sur. A twice-initiated Bwiti practitioner, she began on the clinical side, supporting guests through detox and aftercare at ibogaine clinics. Her commitment deepened after losing her brother to a fentanyl overdose. Paije trained in Gabon with the Missoko Bwiti, completed the Nyembe rites in 2022, and was initiated with the Fong in 2025. Her work combines traditional Bwiti ceremony with EKGs, pharmacist reviews, licensed therapists, and IFS-informed integration. She runs ETÉREO with her husband and co-founder, Fletcher Burdick, and co-founded the Stone West Foundation. Highlights: How iboga differs from isolated ibogaine treatment What medicalized approaches can lose when culture and ceremony are removed Combining Bwiti tradition with clinical screening and emergency preparation Why responsible providers must be willing to say no Iboga root bark versus total alkaloid extract How Bwiti music shapes the ceremonial experience Discomfort, community, and the limits of modern convenience Why iboga requires long-term integration rather than a quick-fix mindset Episode Links: Find full show notes and links here: Episode Sponsors: Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization.
/episode/index/show/psychedelia/id/42807625
info_outline
SSRI Tapering and Psychedelic Readiness - Dr. Josef Witt-Doerring
08/31/2026
SSRI Tapering and Psychedelic Readiness - Dr. Josef Witt-Doerring
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with psychiatrist and TaperClinic founder Dr. Josef Witt-Doerring about antidepressant withdrawal, psychiatric deprescribing, and psychedelic readiness. Find full show notes and links here: Josef explains what he learned reviewing drug safety at the FDA, why withdrawal can be mistaken for relapse, and how tapering often becomes more difficult at lower doses. They also explore the lifestyle foundations of mental health, benzodiazepine withdrawal, and why psychedelic clinics may need far more sophisticated support as increasingly medicated patients seek psilocybin, MDMA, LSD, and ketamine. Dr. Josef Witt-Doerring, MD, is a psychiatrist renowned for his expertise in drug tapering and withdrawal management. With years of experience in clinical psychiatry, he has developed a particular interest and specialization in assisting patients with the safe and effective tapering of psychiatric medications. His approach is patient-centered, focusing on individualized plans that prioritize patient well-being and functioning. He is the founder and medical director of TaperClinic. Highlights: What antidepressant research leaves unanswered Why withdrawal can resemble relapse How lower doses change tapering Five foundations before optimization hacks Benzodiazepines in psychiatric deprescribing Psychedelics versus conventional drug models Insurance pressure on psychedelic clinics Preparing for heavily medicated patients TaperClinic: TaperClinic Free Guide: SSRI Deprescribing & Psychedelic Readiness Training with Dr. Dave Rabin: Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization.
/episode/index/show/psychedelia/id/42569600
info_outline
SSRIs, Psychedelics, & Rethinking Mental Health Treatment - Robert Whitaker
08/24/2026
SSRIs, Psychedelics, & Rethinking Mental Health Treatment - Robert Whitaker
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with investigative journalist Robert Whitaker about the evidence behind psychiatric prescribing, SSRI withdrawal, and what psychedelic medicine can learn from that history. Find full show notes and links here: Whitaker revisits the chemical imbalance theory, long-term antidepressant outcomes, and how psychiatric drugs evolved from short-term interventions toward chronic use. He also explores the social and environmental dimensions of mental health before turning to psychedelic medicine and the risks of recreating a drug-centered model of care. Robert Whitaker is the author of five books, three examining the history of psychiatry. His 2010 book, Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness, won the U.S. Investigative Reporters and Editors award for best investigative journalism. He is president of the Mad in America Foundation and founder of MadinAmerica.com, which features research news and perspectives from an international group of writers interested in rethinking psychiatry. Highlights: How the chemical imbalance story took hold What long-term psychiatric outcomes reveal How antidepressants became long-term treatment SSRI withdrawal versus recurring depression When SSRIs help, and at what cost Mental health beyond individual brain chemistry Psychedelic medicalization and personal agency Community, ritual, and psychedelic experience Episode Links: Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization.
/episode/index/show/psychedelia/id/42519895
info_outline
Ketamine, SSRIs & the Future of Psychedelic Therapy - Dr. Remi Drozd
08/17/2026
Ketamine, SSRIs & the Future of Psychedelic Therapy - Dr. Remi Drozd
In this episode of The Psychedelic Podcast, Paul F. Austin welcomes Dr. Remi Drozd back to explore ketamine, SSRIs, and the changing landscape of psychedelic mental health care. Find full show notes and links here: Since Remi first appeared on the podcast in Episode 182, Lucid Therapeutics has grown from a small ketamine practice into a ten-room interventional mental health clinic offering ketamine treatments, Spravato, TMS, therapy, integration support, and other approaches. Paul and Remi examine one of the less-discussed challenges facing psychedelic medicine: many prospective patients are already taking antidepressants and other psychiatric medications. Remi explains why SSRI tapering needs to be individualized, how ketamine may support some patients through treatment transitions, and what clinicians may need to consider as psilocybin and other psychedelic therapies move closer to mainstream clinical use. Dr. Remi Drozd is a board-certified physician and founder of Lucid Therapeutics in Santa Barbara. After 15 years practicing emergency medicine, he shifted toward more integrative approaches to mental health care. He has trained in ketamine therapy and MDMA-assisted therapy through MAPS. His work focuses on individualized care, expanding access, and preparing for how emerging psychedelic treatments may fit into the existing mental healthcare system. Highlights: The growth of Lucid Therapeutics Expanding access through insurance-based care Navigating ketamine alongside SSRIs Why SSRI tapering must be individualized Withdrawal versus the return of depression Preparing patients for future psilocybin therapy The infrastructure required for psychedelic treatment Bringing longer psychedelic sessions into existing clinics Episode Links: SSRI Deprescribing & Psychedelic Readiness Training: Lucid Therapeutics: Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization.
/episode/index/show/psychedelia/id/42443660
info_outline
Psychedelic Medicine’s Biggest Blind Spots - Dr. Richard Louis Miller
08/10/2026
Psychedelic Medicine’s Biggest Blind Spots - Dr. Richard Louis Miller
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Dr. Richard Louis Miller about what psychedelic medicine must get right as it moves toward broader acceptance. Richard explains why transparent reporting of adverse effects is essential to informed choice, where research still leaves important gaps, and how commercialization could shape access and treatment. They examine 5-MeO-DMT, group therapy, and the limits of one-to-one care. Richard also shares his approach to aging through exercise, real food, rest, and human connection. Dr. Richard Louis Miller is a clinical psychologist, author, and broadcaster with over 65 years of clinical experience in mind-body health. At 87, he continues to practice, teach, and share the tools that have helped thousands of people master anxiety, overthinking, and negative self-talk. He founded the Cokenders Alcohol and Drug Program, which detoxified over 1,500 people without medication, and created the Health Sanctuary at Wilbur Hot Springs, which he directed for 48 years. His work has appeared in Time, Newsweek, NBC News, and CBS News. He has also served as a consultant to the President’s Commission on Mental Health and the U.S. Department of Justice. Episode Highlights: Why psychedelic science needs full transparency Balancing potential benefits against real risks Who psychedelic research frequently leaves out Illegality as an overlooked adverse effect 5-MeO-DMT and the pharmaceutical model Making psychedelic care more accessible Aging as a practice of maintenance Real connection over longevity trends Episode Links: Find full show notes and links here: Episode Sponsors: The at Psychedelic Coaching Institute. - Get a lifetime discount of 10% with code THIRDWAVE at checkout Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can’t and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn’t responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.” Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization.
/episode/index/show/psychedelia/id/42381295
info_outline
Inside the World of Dark Retreats - Ian Gardner
08/04/2026
Inside the World of Dark Retreats - Ian Gardner
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Ian Gardner, founder and CEO of , about dark retreats as an ancient contemplative practice now entering Western culture. This episode is sponsored by The Acraya. Listeners of The Psychedelic Podcast can receive 5% off an Acraya retreat. Visit and use discount code 3WAVE when booking. Ian explains what happens when external stimulation disappears, why boredom and difficult inner material can become central parts of the experience, and how dark retreats compare with psychedelics and extended meditation. He also discusses screening, facilitator training, post-retreat integration, and his vision for technologically supported retreat centers in Costa Rica, Nepal, Bali, and beyond. Episode Highlights: Ancient roots of dark retreat practice What remains when sensory anchors disappear Psychedelics versus gradual inner awakening Boredom as a gateway to deeper material Preparing for several days in darkness Why facilitators need embodied experience Screening for psychological contraindications Technology designed to support retreat safety Integrating before returning to ordinary life Scaling dark retreat centers worldwide Ian Gardner is the founder and CEO of The Acraya, a network of dark meditation retreat sanctuaries. A seasoned entrepreneur, he has founded and exited five companies across biotechnology, renewable energy, and electric vehicles in private and public markets. While earning his MBA from the University of California, Los Angeles, Ian was introduced to yoga and meditation. He later explored Transcendental Meditation, Self-Realization Fellowship, Eckankar, Mudrashram, and the Bridge Path. In 2001, he traveled to Allahabad, India, for the Maha Kumbh Mela before entering a year of seclusion, during which he meditated for up to eight hours daily. Ian has written six books related to esoteric teachings and spent two years working at the Esalen Institute. In 2023, he founded the Church of the Acraya to support the development of dark meditation retreat centers worldwide. He lives in Scottsdale, Arizona, with his wife and children and maintains a daily meditation practice. Epoisode Links: Additional Episode Sponsors: The by Third Wave’s Psychedelic Coaching Institute. - Get a lifetime discount of 10% with code THIRDWAVE at checkout Find full show notes and links here: Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can’t and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn’t responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.” Disclaimer: This episode is provided for educational and entertainment purposes only and should not be considered medical, psychological, or legal advice. Any views, experiences, or claims expressed by the guest are his own and do not necessarily represent those of Third Wave or The Psychedelic Podcast.
/episode/index/show/psychedelia/id/42294330
info_outline
Healing the Need to Prove: Psychedelics and Enoughness - Blake Mycoskie
07/28/2026
Healing the Need to Prove: Psychedelics and Enoughness - Blake Mycoskie
In this episode of The Psychedelic Podcast, Paul F. Austin welcomes TOMS founder Blake Mycoskie for an honest conversation about depression, psychedelics, recovery, and the lifelong need to prove his worth. Find full show notes and links here: Blake explains how an early ayahuasca experience gave him the sense that he had already done enough, even though he had not yet learned to feel that he was enough. He shares what followed after selling TOMS, including a profound depression, a psychiatric diagnosis he later came to question, four medications, and a carefully supported nine-month taper. Paul and Blake also discuss the daily meditation practice that helped reshape his relationship with self-worth, the return of his entrepreneurial energy, his $100 million commitment to psychedelic research and access, and why the future of psychedelic care will require scalable integration, group support, and careful use of emerging AI tools. Blake Mycoskie is the founder of TOMS and creator of the One for One movement, which provided more than 100 million pairs of shoes to children in need. After selling TOMS and navigating a profound depression, he founded WE ARE ENOUGH, a movement supporting mental health organizations and challenging the belief that worth depends on achievement. Blake is also the host of the No Magic Pill podcast and has pledged $100 million to psychedelic research and access. Today, he brings his renewed entrepreneurial energy to ventures including Morning Water and Moovlab. Highlights: Building TOMS through the One for One model Ayahuasca and the feeling of having done enough Depression, misdiagnosis, and psychiatric medication tapering Reworking the belief of never being enough Entrepreneurship and purpose after recovery Funding psychedelic research and access Scaling integration through group support AI therapy and psychedelic integration Episode Links: Blake’s Website: We Are Enough: No Magic Pill: Morning Water: Episode Sponsors: The by Third Wave’s Psychedelic Coaching Institute - Get a lifetime discount of 10% with code THIRDWAVE at checkout Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can’t and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn’t responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes. Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization.
/episode/index/show/psychedelia/id/42236585
info_outline
Inside the God Molecule: An Honest Look at 5-MeO-DMT
07/22/2026
Inside the God Molecule: An Honest Look at 5-MeO-DMT
In this solo episode, Paul F. Austin offers a candid introduction to 5-MeO-DMT, one of the shortest and most intense psychedelic experiences. Find full show notes and links here: Paul distinguishes synthetic 5-MeO-DMT from Bufo, compares it with N,N-DMT and psilocybin, and examines the risks that social media narratives often leave out. He also explores low-dose versus breakthrough work, nervous system readiness, medication interactions, facilitator screening, reactivations, ecological responsibility, and why integration may matter far more than the experience itself. Paul F. Austin is an entrepreneur, educator, and pioneer in the psychedelic field. He is the founder of , a leading platform dedicated to psychedelic education, and the , which trains coaches and practitioners to responsibly support psychedelic experiences and integration. As host of The Psychedelic Podcast, Paul has interviewed hundreds of researchers, clinicians, Indigenous wisdom keepers, entrepreneurs, and cultural innovators. His work focuses on psychedelics, leadership, personal development, mental health, and cultural transformation. Highlights: 5-MeO-DMT beyond the social media hype Synthetic 5-MeO-DMT versus Bufo How 5-MeO differs from N,N-DMT Low-dose work versus complete ego dissolution Why nervous system readiness matters Medication interactions and physical safety How to evaluate a 5-MeO facilitator Why integration outlasts the experience Episode Links: The by Third Wave’s Psychedelic Coaching Institute. Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization.
/episode/index/show/psychedelia/id/42179105
info_outline
Posting About Psychedelics in the Age of AI - Victoria J. Cvitanovic
07/13/2026
Posting About Psychedelics in the Age of AI - Victoria J. Cvitanovic
In this special replay of a past Psychedelic Coaching Institute webinar, Paul F. Austin is joined by Victoria J. Cvitanovic, attorney and leader of the Psychedelic Medicine and AI Governance practices at Rudick Law Group, for a practical conversation on how AI is reshaping psychedelic practice. Find full show notes and links here: Together, Paul and Victoria explore why psychedelic content can get flagged online, how automated moderation systems are changing what practitioners can safely post, and why educational content may still be misread by platforms like Meta. They also discuss payment processor risk, account freezes, client data privacy, AI note-taking tools, website compliance, and the legal nuance practitioners need to understand before building or growing their work online. Victoria J. Cvitanovic is a psychedelic medicine, cannabis, wellness, and tech attorney. In addition to her law degree, Victoria holds CIPP-US and AIGP certifications from the International Association of Privacy Professionals. She leads the Psychedelic Medicine and AI Governance practices at Rudick Law Group, where she also serves as the firm’s Data Privacy Officer. Her work covers cybersecurity, data privacy, AI governance, regulatory compliance, corporate formation, licensing, and healthcare integration. Highlights: AI moderation and psychedelic content Why psychedelic posts get flagged online Posting about psychedelics responsibly Payment processors and risk reviews What to do when funds freeze Data privacy in client work AI tools and practitioner liability Website compliance basics Episode Links: Episode Sponsors: The by The Psychedelic Coaching Institute. - Get a lifetime discount of 10% with code THIRDWAVE at checkout Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can’t and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn’t responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.”
/episode/index/show/psychedelia/id/42054135
info_outline
Why Psychedelic Therapy Needs to Be Relational - Steven C. Hayes, Ph.D.
07/06/2026
Why Psychedelic Therapy Needs to Be Relational - Steven C. Hayes, Ph.D.
In this episode of The Psychedelic Podcast, Paul F. Austin welcomes Steven C. Hayes, Ph.D., originator of Acceptance and Commitment Therapy, creator of Relational Frame Theory, and one of the most cited psychologists in the world. Full Show Notes: Hayes reflects on his early experiences in the Summer of Love, why psychedelics were never meant to be treated as a party, and how those formative explorations helped shape his lifelong work on psychological flexibility. Paul and Steven explore what psychedelics can reveal about the nature of self, the role of preparation and context in safe outcomes, and why psychedelic therapy must not be reduced to a patented, “script and go” biomedical model. Their conversation also examines ACT, trauma, attachment, group experience, spiritual community, and the importance of honoring each person’s unique path rather than forcing transformation into averages, labels, or protocols. Steven C. Hayes, Ph.D., is a Nevada Foundation Professor of Psychology Emeritus at the University of Nevada, Reno and President of the Institute for Better Health, a 45-year-old charitable organization that promotes quality in mental and behavioral health services. He is the originator of Acceptance and Commitment Therapy, creator of Relational Frame Theory, and a co-developer of Process-Based Therapy. Hayes has authored nearly 750 scientific articles and 48 books, including Get Out of Your Mind and Into Your Life and A Liberated Mind. His methods are distributed worldwide by the World Health Organization and other major scientific agencies, and are commonly used in psychedelic-assisted therapy. His TEDx talks and blogs have been viewed or read by more than five million people, and he is among the most cited psychologists in the world. Highlights: Psychedelics as tools of the mind The Summer of Love’s unfinished lessons Self as context and spiritual awareness Why good trips feel like coming home ACT as psychological flexibility Preparation, safety, and lasting change The danger of “script and go” psychedelics Group ceremony and relational healing Particularity, averages, and human uniqueness Psychedelics beyond the therapy frame Episode Links: Episode Sponsors: The by Third Wave’s Psychedelic Coaching Institute. - Get a lifetime discount of 10% with code THIRDWAVE at checkout Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can’t and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn’t responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.”
/episode/index/show/psychedelia/id/41972595
info_outline
Psychedelic Preparation: Why Safety Starts in the Body - Dave M. Rabin, M.D., Ph.D.
06/29/2026
Psychedelic Preparation: Why Safety Starts in the Body - Dave M. Rabin, M.D., Ph.D.
In this conversation, Paul F. Austin speaks with Dr. Dave Rabin, neuroscientist, board-certified psychiatrist, and co-founder of Apollo Neuroscience, about one of the most important questions in psychedelic work: why do some journeys become overwhelming, destabilizing, or difficult to integrate? Find full show notes and links here: Dave explains why safety is not just a matter of set, setting, or a strong screening form. It is a physiological state in the nervous system. Together, Paul and Dave explore how fear, trauma, and dysregulation can shape a person’s ability to receive and process a psychedelic experience, and why preparation must include a deeper understanding of the body. The conversation also covers pre-session nervous system assessment, vagus nerve activity, HRV, haptic vibration, breathwork, therapeutic touch, consent, and the role of tools like Apollo Neuro in helping clients feel safe enough to surrender, process, and integrate. Dr. David Rabin, MD, PhD, is a neuroscientist, board-certified psychiatrist, health-tech entrepreneur, and inventor who has studied the impact of chronic stress in humans for more than a decade. He is the co-founder and Chief Innovation Officer at Apollo Neuroscience, and co-founder and executive director of the Board of Medicine, a nonprofit organization establishing evidence-based clinical guidelines for the safe use of unregulated alternative medicines, including plant medicines. His research focuses on non-invasive therapies for treatment-resistant conditions, trauma recovery, psychedelic-assisted psychotherapy, and the neurobiology of belief. Highlights: Why safety is physiological Beyond set and setting How fear interrupts healing Pre-session nervous system assessment MDMA and the safety cascade Haptic vibration and soothing touch HRV as a preparation signal Breathwork for embodied regulation Consent and therapeutic touch Scaling safe psychedelic care Episode Links: Episode Sponsors: The by Third Wave’s Psychedelic Coaching Institute. The at Psychedelic Coaching Institute. - Get a lifetime discount of 10% with code THIRDWAVE at checkout These show links may contain affiliate links. Third Wave receives a small percentage of the product price if you purchase through the above affiliate links. Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization. Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can’t and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn’t responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.
/episode/index/show/psychedelia/id/41789500
info_outline
Be the Work: From Human Doing to Human Being - Stefanie Kleine, Ph.D.
06/22/2026
Be the Work: From Human Doing to Human Being - Stefanie Kleine, Ph.D.
In this episode of The Psychedelic Podcast, Paul F. Austin sits down with Dr. Stefanie Kleine, psychospiritual coach, author of BE THE WORK, and co-founder of The Sacred House of Eden, to explore the hidden wound that often drives achievement and why lasting transformation happens on the level of being rather than doing. Find full show notes and links here: Drawing on more than two decades of experience coaching executives, founders, athletes, physicians, and other high performers, Stefanie shares how her first psychedelic experience revealed the pattern beneath a lifetime of accomplishment and opened a path toward deeper self-acceptance. She explains her framework of grasping versus generative desire, the Be-Do-Have inversion, and why many personal growth and wellness practices can unintentionally reinforce the same striving they aim to heal. The conversation also explores psychedelic integration, Internal Family Systems-informed coaching, conscious leadership, nervous system regulation, AI and human connection, and what it means to move from proving your worth to inhabiting it. Throughout, Stefanie offers a grounded perspective on why ceremony is only the beginning and how true transformation unfolds through the choices we make afterward. Dr. Stefanie Kleine is a psychospiritual coach, guide, and author who has spent more than 23 years coaching executives, founders, attorneys, physicians, athletes, and other high performers. She holds a master's degree and PhD in psychology and is the co-founder of The Sacred House of Eden, one of the leading psychedelic retreat centers in the United States. Since 2018, she has guided more than 1,600 ceremonies and integration processes. Her work centers on what she calls the Be-Do-Have Inversion: the shift from human doing to human being. She is the author of BE THE WORK: The Shift from Human Doing to Human Being and has been featured in Bloomberg, The Wall Street Journal, and Forbes. Highlights: The wound beneath high achievement Stefanie's first psychedelic awakening Grasping versus generative desire Why transformation happens on the being level The Be-Do-Have inversion Psychedelic integration beyond ceremony Internal Family Systems and coaching Conscious leadership after psychedelic work AI, humanity, and authentic connection Moving from striving to wholeness Episode Links: Episode Sponsors: The by Third Wave’s Psychedelic Coaching Institute. The at Psychedelic Coaching Institute. - Get a lifetime discount of 10% with code THIRDWAVE at checkout Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization. Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can’t and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn’t responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.
/episode/index/show/psychedelia/id/41698130
info_outline
Psilocybin Mushrooms: Strains, Potency, and Experience - Paul F. Austin
06/15/2026
Psilocybin Mushrooms: Strains, Potency, and Experience - Paul F. Austin
In this solo episode of The Psychedelic Podcast, Paul F. Austin explores one of the most common questions in the psychedelic space: which psilocybin mushroom strain is actually best? Find full show notes and links here: Moving beyond the search for the "strongest" mushroom, Paul breaks down the factors that truly shape a meaningful experience, including strain selection, potency, preparation methods, storage practices, individual sensitivity, and the critical role of context. Drawing on years of experience through Third Wave and the Psychedelic Coaching Institute, Paul compares popular strains such as Golden Teacher, Penis Envy, Ghost, Enigma, and Psilocybe natalensis. He also explains why preparation methods like lemon tekking matter, how to think about microdosing versus macrodosing, and why integration remains one of the most important variables in long-term outcomes. Paul F. Austin is an entrepreneur, educator, and pioneer in the psychedelic field. He is the founder of Third Wave, a leading platform dedicated to psychedelic education, and the Psychedelic Coaching Institute, which trains coaches and practitioners to responsibly support psychedelic experiences and integration. As the host of The Psychedelic Podcast, Paul has interviewed hundreds of leading researchers, clinicians, indigenous wisdom keepers, entrepreneurs, and cultural innovators at the forefront of the psychedelic renaissance. Highlights: Why stronger isn't always better The myth of the strongest strain Golden Teacher vs. Penis Envy Understanding Ghost and Enigma Psilocybe natalensis explained How lemon tek changes the journey Why storage affects potency Microdosing vs. macrodosing Context shapes psychedelic outcomes Integration beyond the peak experience Episode Links: Episode Sponsors: The by Third Wave’s Psychedelic Coaching Institute. The at Psychedelic Coaching Institute. - Get a lifetime discount of 10% with code THIRDWAVE at checkout Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization. Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can’t and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn’t responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.
/episode/index/show/psychedelia/id/41629630
info_outline
Choosing the Right Microdose: Psilocybin, LSD, Huachuma & More - Paul F. Austin
06/08/2026
Choosing the Right Microdose: Psilocybin, LSD, Huachuma & More - Paul F. Austin
In this special solo episode, adapted from a recent live training, Paul F. Austin explores one of the most important and often overlooked realities of microdosing: different substances create different outcomes. Find full show notes and links here: Drawing on more than a decade of experience in psychedelic education and coaching, Paul compares psilocybin, LSD, huachuma (San Pedro), ketamine, and iboga through the lens of client goals, nervous system regulation, emotional processing, cognitive performance, and contraindications. Paul explains why generic microdosing protocols often fall short, how practitioners can better match substances to individual needs, and why context, preparation, and integration matter far more than any single medicine. He also shares why huachuma has become the foundation of the Psychedelic Coaching Institute's microdosing methodology and offers guidance for practitioners looking to support clients with greater precision and care. Highlights: Why generic microdosing protocols can fall short How psilocybin supports emotional processing and inner work LSD's role in focus, creativity, and physiological performance Why huachuma may be especially useful for nervous system regulation Ketamine's role in SSRI tapering and clinical support Iboga's potential for neurodegenerative conditions and brain injury How to match substances to a client's goals and baseline state Why contraindications and clinical-grade intake matter How microdosing can support post-journey integration Why "more medicine" is not always the answer Episode Links: Episode Sponsors: The by Third Wave’s Psychedelic Coaching Institute. The at Psychedelic Coaching Institute. - Get a lifetime discount of 10% with code THIRDWAVE at checkout Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization. Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can’t and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn’t responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.
/episode/index/show/psychedelia/id/41545130
info_outline
Amazonian Tobacco Medicine: Dieta, Ceremony, and Lineage - Jason Grechanik
05/28/2026
Amazonian Tobacco Medicine: Dieta, Ceremony, and Lineage - Jason Grechanik
In this episode of The Psychedelic Podcast, Paul F. Austin welcomes Jason Grechanik, master tabaquero and host of The Universe Within Podcast, for a deep exploration of sacred tobacco as Amazonian plant medicine. Find full show notes and links here: Sacred tobacco is usually understood in the West through the lens of cigarettes, addiction, and commercial misuse. But in Amazonian traditions, Nicotiana rustica is understood very differently: as a master plant, a protector, and a powerful medicine that requires lineage, discernment, and right relationship. Drawing from nearly a decade of Amazonian immersion and more than 1,000 people guided through plant ceremonies, Jason shares how tobacco is worked with in dieta, ayahuasca ceremony, energetic protection, and direct relationship with plant spirits. Paul and Jason also discuss cannabis, indigenous cosmologies, safety, and what tobacco’s history can teach the modern psychedelic movement about power, humility, and proper containers. Jason Grechanik is a master tabaquero trained in the Mamankunawa tradition under curandero Don Ernesto Garcia Torres. With nearly a decade of Amazonian immersion and more than 1,000 people guided through plant ceremonies, Jason spent many years at the renowned Shipibo healing center Temple of the Way of Light. He is the host of The Universe Within Podcast, with 180+ episodes and 20K+ monthly listeners, co-founder of the Nicotiana Rustica project, and has been featured in DoubleBlind Magazine. Highlights: Jason’s path into Amazonian tobacco medicine Tobacco beyond commercial cigarettes Why tobacco is considered a master plant Dieta as direct plant relationship Tobacco as portal and protector Ayahuasca, diagnosis, and plant doctors Safety, toxicity, and proper containers Jaguar and hummingbird tobacco archetypes Cannabis, dreams, and plant relationship Lessons for the psychedelic renaissance Episode Links: Episode Sponsors: The by Third Wave’s Psychedelic Coaching Institute. - Get a lifetime discount of 10% with code THIRDWAVE at checkout Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization. Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can’t and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn’t responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.
/episode/index/show/psychedelia/id/41448675
info_outline
Ketamine for Couples: Transforming Relational Patterns - Chandra Estelle Khalifian, Ph.D
05/25/2026
Ketamine for Couples: Transforming Relational Patterns - Chandra Estelle Khalifian, Ph.D
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Dr. Chandra Estelle Khalifian, a clinical psychologist, relationship researcher, and co-founder of Enamory, about the intersection of attachment science, couples therapy, and psychedelic-assisted healing. Find full show notes and links here: Drawing from her work in ketamine-assisted couple therapy and MDMA research, Chandra explores how relationships are shaped by nervous system regulation, attachment wounds, and patterns developed long before adulthood. The conversation examines how ketamine and MDMA can help couples move through rigidity, betrayal, grief, and disconnection by creating greater emotional openness and flexibility. Paul and Chandra also dive into conscious uncoupling, relational growth, community, and the deeper distinction between love as a feeling versus love as a practice. Chandra Khalifian, Ph.D. is a clinical psychologist, researcher, and educator specializing in psychedelic-assisted couple therapy. She co-founded Enamory, alongside Dr. Kayla Knopp, a private practice clinic, training institute, and research foundation based in San Diego, California. Their work focuses on ketamine-assisted couple therapy, including clinical data collection and therapist training programs designed to support practitioners integrating psychedelic-assisted couple therapy into their practices. Chandra’s work bridges attachment science, nervous system regulation, relationship psychology, and psychedelic medicine. Highlights: How Attachment Shapes Adult Relationships Ketamine for Breaking Relational Rigidity Why Secure Attachment Feels Safe MDMA for Betrayal & Repair Conscious Uncoupling Without Hatred Why Love Alone Isn’t Enough Healing Grief Through Psychedelic Therapy Couples Therapy as Nervous System Work Episode Links: Episode Sponsors: The at Psychedelic Coaching Institute. - Get a lifetime discount of 10% with code THIRDWAVE at checkout Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization. Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can’t and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn’t responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.
/episode/index/show/psychedelia/id/41386290
info_outline
Why Group Psychedelic Therapy Matters - Dr. Lauren Macdonald
05/18/2026
Why Group Psychedelic Therapy Matters - Dr. Lauren Macdonald
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Dr. Lauren Macdonald, a clinical trial physician and psychedelic therapist, about the evolving role of community in psychedelic-assisted therapy. Find full show notes and links here: Lauren shares insights from her work at Imperial College London, where she contributed to research on psilocybin for anorexia and fibromyalgia, as well as DMT for treatment-resistant depression. She reflects on the limitations of purely individual therapeutic models and explores how group-based approaches can foster deeper healing through connection, shared experience, and what she describes as communitas. The conversation also touches on the contrast between clinical and ceremonial settings, the role of group dynamics in emotional processing, and the challenges of access and affordability as psychedelic therapy expands. Dr. Lauren Macdonald has a background in psychiatry, psychedelic-assisted therapy, and group retreat facilitation, working at the intersection of science, soul, and spirit. At the Centre for Psychedelic Research at Imperial College London, she has served as a clinical trial doctor and psychedelic therapist on studies exploring psilocybin for anorexia and fibromyalgia, and DMT for treatment-resistant depression. Highlights: Psilocybin therapy in clinical research Limits of individual therapy models Why group work deepens healing Communitas and shared experience Bridging science and spirituality Psychedelics in palliative care Relational safety in altered states Episode Links: Episode Sponsors: The at Psychedelic Coaching Institute. The by Third Wave’s Psychedelic Coaching Institute. - Get a lifetime discount of 10% with code THIRDWAVE at checkout Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization. Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can’t and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn’t responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.
/episode/index/show/psychedelia/id/41094665
info_outline
Psychedelics and Myth: Why Story Shapes Transformation - David Adam Burns
05/11/2026
Psychedelics and Myth: Why Story Shapes Transformation - David Adam Burns
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with David Adam Burns, a transformational coach, artist, and founder of The Mysteries, about what may be missing from today’s psychedelic conversation. Find full show notes and links here: David challenges the emphasis on insight in psychedelic work, suggesting that deeper transformation comes through presence, healing, and embodied evolution. He outlines a framework for healing through integration, purification, and emotional “thawing,” and explains why presence may be the most important skill for navigating psychedelic experiences. They also explore myth and storytelling as tools for collective growth, including David’s work with The Mysteries and Earthsong, a retelling of the Persephone myth, and discuss the role of community, leadership, and stewardship in shaping the future of psychedelics. David Adam Burns is a transformational coach, artist, and facilitator devoted to helping human beings remember who they are. Since 2015, he has guided leaders through deep personal transformation in his one-on-one practice and co-founded The Mysteries, an artists’ collective dedicated to expressing the ineffable through myth and performance. Highlights: Why insight is often overvalued Healing as integration, purification, and thawing Presence as the core psychedelic skill Story and myth as collective technologies The role of community in transformation Why leadership determines long-term outcomes Episode Links: Episode Sponsors: The at Psychedelic Coaching Institute. The by Third Wave’s Psychedelic Coaching Institute. - Get a lifetime discount of 10% with code THIRDWAVE at checkout Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization. Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can’t and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn’t responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.
/episode/index/show/psychedelia/id/41097095
info_outline
IFS & Psychedelics: A Guide for Practitioners - Heather Smith
05/04/2026
IFS & Psychedelics: A Guide for Practitioners - Heather Smith
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Heather Smith, founder of The Moxie School and a certified Internal Family Systems (IFS) therapist, about the intersection of parts work and psychedelic healing. Find full show notes and links here: Heather explains how IFS offers a practical framework for working with what arises during psychedelic experiences. She describes IFS as an approach that helps people stay present with different parts of themselves, especially when difficult or unexpected material comes up. The conversation explores how psychedelic experiences can bring awareness to underlying patterns and past experiences, and why that awareness on its own often doesn’t lead to lasting change. They also discuss common misconceptions about combining IFS with psychedelics, the role of preparation and integration, and how working directly with parts supports more stable change over time. Highlights: Misconceptions about IFS in psychedelic work IFS as a mindset, not a method How psychedelics reveal internal parts Why insight alone isn’t enough The unburdening process in healing Working with fear and difficult experiences Preparation and integration as core skills Practitioner integrity and embodied practice Heather Smith is a visionary in the field of psychedelic healing, blending Internal Family Systems (IFS) therapy with expanded states of consciousness to catalyze deep transformation. A Certified IFS therapist, she has completed Levels 1–3 of training and served as a Program Assistant multiple times. She is the founder of The Moxie School®, where she trains psychedelic facilitators in IFS-informed approaches and supports both personal and professional development through immersive training and retreat experiences. Episode Links: Episode Sponsors: The at Psychedelic Coaching Institute. The by Third Wave’s Psychedelic Coaching Institute. - Get a lifetime discount of 10% with code THIRDWAVE at checkout Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization. Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can’t and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn’t responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.
/episode/index/show/psychedelia/id/41071800
info_outline
Right to Try Psilocybin: Law, Death, and Dignity - Kathryn L. Tucker, J.D.
04/27/2026
Right to Try Psilocybin: Law, Death, and Dignity - Kathryn L. Tucker, J.D.
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Kathryn L. Tucker, J.D., a leading civil rights attorney and advocate for end-of-life autonomy, about the legal effort to expand access to psilocybin-assisted therapy for patients facing serious illness. Find full show notes and links here: Kathryn shares how decades of work in right-to-die litigation led her to recognize a critical gap in palliative care, addressing psychological and existential suffering at the end of life. Drawing from emerging clinical research, she explains why psilocybin may offer meaningful relief for anxiety, depression, and distress in terminal patients. The conversation explores the legal pathways being pursued to make this treatment accessible, including Right to Try laws, federal litigation with the DEA, and efforts to reschedule psilocybin. Kathryn also reflects on the broader cultural and ethical implications of allowing individuals greater choice in how they approach death. Kathryn L. Tucker, JD, is a nationally recognized leader in advancing improved care for seriously ill and dying patients. She has held leadership roles across multiple nonprofit organizations, including the National Psychedelics Association, the End of Life Liberty Project, and Compassion & Choices. Tucker has litigated landmark cases before the U.S. Supreme Court, including Washington v. Glucksberg and Vacco v. Quill, and has played a key role in both end-of-life litigation and psychedelic policy advocacy. Highlights: Right to Try laws explained Psilocybin as investigational medicine DEA barriers to patient access Litigation strategies for psychedelic access Rescheduling psilocybin efforts Palliative care gaps in mental suffering Legal vs underground psychedelic Episode Links: Episode Sponsors: The at Psychedelic Coaching Institute. The by Third Wave’s Psychedelic Coaching Institute. - Get a lifetime discount of 10% with code THIRDWAVE at checkout Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization. Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can’t and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn’t responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.
/episode/index/show/psychedelia/id/40984960
info_outline
Healing Before Leading: Psychedelics and Political Integrity - Laura Dunn
04/20/2026
Healing Before Leading: Psychedelics and Political Integrity - Laura Dunn
Healing Before Leading: Psychedelics and Political Integrity In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Laura Dunn, civil rights attorney and congressional candidate, about trauma, leadership, and the role of psychedelic healing. Find full show notes and links here: Laura shares how her work advocating for survivors led her to confront the deeper limitations of legal and institutional systems. While policy change can create meaningful protections, it often fails to address the underlying trauma individuals carry. They explore how psychedelic experiences became part of her personal healing journey, and how that informs her approach to leadership, public service, and political integrity. Laura Dunn is an award-winning civil rights attorney, former public school teacher, and congressional candidate in New York’s 12th District. She helped shape Title IX protections, contributed to the Violence Against Women Act reauthorization, and founded SurvJustice, a nonprofit supporting survivors of sexual violence. Her work bridges advocacy, policy, and trauma-informed leadership. Highlights: From survivor advocacy to policy reform Limits of legal systems in trauma healing Why leadership requires inner work Psychedelics as tools for self-awareness Breaking stigma in political leadership Bipartisan support for reform Veterans and policy momentum Trauma and leadership integrity A vision for conscious governance Episode Links: Episode Sponsors: The at Psychedelic Coaching Institute. The by Third Wave’s Psychedelic Coaching Institute. - Get a lifetime discount of 10% with code THIRDWAVE at checkout Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization. Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can’t and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn’t responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.
/episode/index/show/psychedelia/id/40809280
info_outline
Western Philosophy on Drugs: Consciousness, Dreams, and Reality - Justin Smith-Ruiu
04/13/2026
Western Philosophy on Drugs: Consciousness, Dreams, and Reality - Justin Smith-Ruiu
Western Philosophy on Drugs: Consciousness, Dreams, and Reality In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Dr. Justin Smith-Ruiu about how psychedelic experiences challenge long-standing assumptions about consciousness, perception, and reality. Find full show notes and links here: Justin explains how Western philosophy has historically privileged rational, sober, and waking states of mind, often dismissing dreams and altered states as unreliable. He explores how psychedelic experiences push against these assumptions, raising deeper questions about knowledge, language, and what counts as real. The conversation also examines the tension between therapeutic and existential uses of psychedelics, and how medicalization may shape the cultural role these substances play moving forward. Justin Smith-Ruiu is a professor of history and philosophy of science at the Université Paris Cité and author of On Drugs: Psychedelics, Philosophy, and the Nature of Reality. His work explores intellectual history, consciousness, and the limits of rational thought, and he writes regularly for Harper’s, WIRED, and The New York Times. Highlights: How philosophy excludes altered states Why dreams are dismissed as unreliable Psychedelics and limits of rationality Language and ineffability of experience Therapeutic vs existential frameworks Medicalization and cultural impact Philosophy beyond sober cognition Episode Links: Episode Sponsors: The at Psychedelic Coaching Institute. The by Third Wave’s Psychedelic Coaching Institute. - Get a lifetime discount of 10% with code THIRDWAVE at checkout Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization. Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can’t and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn’t responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.
/episode/index/show/psychedelia/id/40780315
info_outline
Can Ketamine Help Benzodiazepine Withdrawal? - Melissa Bond & Dr. Amy de la Garza
04/06/2026
Can Ketamine Help Benzodiazepine Withdrawal? - Melissa Bond & Dr. Amy de la Garza
Can Ketamine Help Benzodiazepine Withdrawal? - Melissa Bond & Dr. Amy de la Garza In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Melissa Bond and Dr. Amy de la Garza about the hidden risks of benzodiazepines, the reality of dependency, and what recovery can require. Find full show notes and links here: Melissa shares her experience of becoming dependent on prescribed medication, and the physical and emotional challenges of withdrawal. Dr. de la Garza brings a clinical perspective, explaining how benzodiazepines affect the nervous system and why withdrawal can be prolonged and destabilizing. The conversation also looks at where conventional care often falls short, and how more integrative approaches are beginning to emerge. This includes the use of low-dose ketamine as a potential tool to support the nervous system during withdrawal, particularly in more complex or prolonged cases. Melissa Bond is a narrative journalist and poet. Her memoir Blood Orange Night, which chronicles her experience with benzodiazepine dependency, was published by Simon & Schuster and recognized by The New York Times as one of the best audiobooks of 2022. Her work has appeared on PBS, The New York Times Podcast, RadioWest, and TEDx. Dr. Amy de la Garza is a board-certified physician in Family and Addiction Medicine, a certified Functional Medicine practitioner, and co-founder of Nosis Health, a virtual outpatient addiction medicine platform. Her work integrates functional, lifestyle, and emerging therapies, including ketamine-assisted treatment, to support recovery. Highlights: Melissa Bond’s experience with benzodiazepine dependency and withdrawal How prescribed use can gradually lead to physical dependence Why benzodiazepine withdrawal can be prolonged and destabilizing The neurological effects of benzodiazepines on the nervous system Gaps in conventional approaches to anxiety and addiction treatment The role of functional and lifestyle medicine in recovery How low-dose ketamine is being explored to support withdrawal What a more integrative, whole-person model of care can look like Episode Links: Episode Sponsors: The at Psychedelic Coaching Institute. The by Third Wave’s Psychedelic Coaching Institute. - Get a lifetime discount of 10% with code THIRDWAVE at checkout Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization. Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can’t and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn’t responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.
/episode/index/show/psychedelia/id/40718755
info_outline
Bioengineering Psychedelics: Rethinking Sourcing and Scale - Jeffrey E. Gerst, Ph.D.
03/30/2026
Bioengineering Psychedelics: Rethinking Sourcing and Scale - Jeffrey E. Gerst, Ph.D.
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with a molecular geneticist exploring what it could look like to rethink how psychedelic medicines are sourced at a fundamental level. Find full show notes and links here: Jeffrey Gerst explains how his work in RNA biology and gene expression has led him to explore bioengineering as a way to produce psychedelic compounds without relying on wild harvesting or traditional chemical synthesis. The conversation looks at how cells organize and communicate, and how those same biological principles could be used to create more sustainable and scalable systems for medicine production. Paul and Jeff also reflect on the broader implications of this shift, from environmental stewardship to the long-term integrity of the psychedelic ecosystem. Professor Jeffrey Gerst is a molecular geneticist and Full Professor at the Weizmann Institute of Science, where he studies how cells regulate gene expression through RNA trafficking and localized protein synthesis. His research has advanced understanding of how mRNA moves within and between cells, revealing new forms of cellular communication and potential applications in therapeutic delivery. More recently, his work has expanded into the bioengineering of psychedelic compounds, with a focus on developing sustainable, scalable, and ethical methods of production. Highlights: Why sourcing is becoming a central challenge in psychedelics Bioengineering as a scalable alternative to wild harvesting How RNA biology informs new approaches to medicine production The limits of “natural” when demand increases Environmental risks of large-scale psychedelic use How yeast and cells can produce psychedelic compounds Balancing biotechnology with traditional practices What sustainable access could look like in the future The evolving relationship between science and psychedelics Episode Links: Episode Sponsors: Psychedelic Coacing Institute's in Costa Rica - a transformative retreat for personal and professional growth. The at Psychedelic Coaching Institute. The by Third Wave’s Psychedelic Coaching Institute. - Get a lifetime discount of 10% with code THIRDWAVE at checkout Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization. Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can’t and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn’t responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.
/episode/index/show/psychedelia/id/40638235
info_outline
Herbal Ecstasy & The Billion Dollar Smart Drug Boom - Shaahin Cheyene
03/23/2026
Herbal Ecstasy & The Billion Dollar Smart Drug Boom - Shaahin Cheyene
Herbal Ecstasy & The Billion Dollar Smart Drug Boom In this episode of The Psychedelic Podcast, Paul F. Austin sits down with entrepreneur Shaahin Cheyene, creator of the controversial 1990s supplement “Herbal Ecstasy,” which helped launch the legal smart-drug movement. Find full show notes and links here: Shaahin shares how he built a multimillion-dollar business at just fifteen by creating a legal herbal alternative to MDMA during a shortage in the rave scene. The conversation explores 1990s rave culture, the ethics of prohibition, and how natural supplements intersect with psychedelics, entrepreneurship, and personal freedom. They also discuss his later ventures in Amazon commerce, podcast media, and YouTube. Shaahin Cheyene is the creator of Herbal Ecstasy, a supplement that helped spark the legal smart-drug movement in the 1990s. He built the business as a teenager into a multimillion-dollar company. Over the past three decades, Shaahin has become an award-winning entrepreneur, Amazon expert, inventor, author, and filmmaker whose ventures have generated over a billion dollars in revenue. He is the founder of PodcastCola and Viral Mirage. Through his businesses, Shaahin continues to mentor entrepreneurs and develop health and wellness products focused on optimizing human performance. Highlights: Creating Herbal Ecstasy at age fifteen The MDMA shortage that created opportunity Rave culture and the 1990s club scene Natural supplements as legal alternatives Freedom, regulation, and drug policy debates Health and wellness entrepreneurship Building product brands in emerging markets Podcasting and YouTube as influence platforms Episode Links: Episode Sponsors: The at Psychedelic Coaching Institute. The by Third Wave’s Psychedelic Coaching Institute. - Get a lifetime discount of 10% with code THIRDWAVE at checkout Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization. Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can’t and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn’t responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.
/episode/index/show/psychedelia/id/40548810
info_outline
Ibogaine for the Injured Brain: A New Model for Treatment - Jonathan Dickinson
03/16/2026
Ibogaine for the Injured Brain: A New Model for Treatment - Jonathan Dickinson
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Jonathan Dickinson, CEO and Co-Founder of Ambio Life Sciences, about the evolving role of ibogaine in psychedelic medicine. Listen to the full episode: https://thethirdwave.co/podcast/episode-347/?ref=278 Jonathan shares his path from leading the Global Ibogaine Therapy Alliance to helping build one of the field’s most prominent ibogaine treatment organizations. Together they explore ibogaine’s expanding therapeutic potential for traumatic brain injury, addiction, and neurological conditions, along with the clinical realities of delivering this powerful medicine safely. They also discuss the challenges of scaling ibogaine treatment, the importance of preparation and integration, and how traditional Bwiti knowledge from Gabon continues to shape ethical and culturally grounded approaches to this work. Jonathan Dickinson is the CEO and Co-Founder of Ambio Life Sciences and a leading expert on ibogaine therapy. With more than 15 years of experience in psychedelic research, clinical care, and traditional practice, he has helped shape global safety standards for ibogaine treatment. A Mexico-licensed psychologist and former Executive Director of the Global Ibogaine Therapy Alliance, Jonathan has published research on ibogaine’s therapeutic potential for trauma, traumatic brain injury, and neurological conditions. He has also been initiated into the Bwiti traditions of Gabon and holds a Nagoya-compliant export license for Tabernanthe iboga root. Highlights: Jonathan Dickinson’s path from the Global Ibogaine Therapy Alliance to Ambio Life Sciences How ibogaine treatment expanded beyond opioid detox The growing use of ibogaine for traumatic brain injury and veterans’ recovery Why ibogaine treatment requires extensive medical screening and preparation The importance of integration and community support after treatment What Bwiti traditions in Gabon teach about working with iboga The challenges of scaling ibogaine treatment safely Why ibogaine may create a longer window for lasting change
/episode/index/show/psychedelia/id/40494775